References
- 1. Hennington BS, Zhang H, Miller MT, Granger JP, Reckelhoff JF. Angiotensin II stimulates synthesis of endothelial nitric oxide synthase. Hypertension. 1998; 3:283-8.10.1161/01.HYP.31.1.283
- 2. Moreno C, Lopez A, Llinas MT, Rodriguez F, Lopez- Farre A, Nava E, et al. Changes in NOS activity and protein expression during acute and prolonged ANG II administration. Am J Physiol. 2002; 282:R31-7.
- 3. Kurtz A, Gotz K, Hamann M, Wagner C. Stimulation of renin secretion by NO doners is related to the cAMP pathway. Am J Physiol. 1998; 274:F709-12.
- 4. Persson PB, Baumann JE, Ehmke H, Hackenthal E, Kirchheim HR, Nafz B. Endothelium-derived NO stimulates pressure-dependent renin release in conscious dogs. Am J Physiol. 1993; 264:F943-7.
- 5. Manucha W. Biochemical-molecular markers in unilateral ureteral obstruction. Biocell 2007; 31:1-12.
- 6. Klahr S, Morrissey J. Obstructive nephropathy and renal fibrosis. Am J Physiol. 2002; 283:F861-75.
- 7. Ishidoya S, Morrissey J, McCracken R, Reyes A, Klahr S. Angiotensin receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int. 1995; 47:1285-94.
- 8. Ito K, Chen J, El Chaar M, Stern JM, Seshan SV, Khodadadian JJ, et al. Renal damage progresses despite improvement of renal function after relief of unilateral ureteral obstruction in adult rats. Am J Physiol. 2004; 287:F1283-93.
- 9. Chang B, Mathew R, Palmer L, Valderrama E, Trachtman H. Nitric oxide in obstruction uropathy: Role of endothelial nitric oxide synthase. J Urology. 2002; 168:1801-14.
- 10. Hegarty NJ, Young LS, Kirwan CN, O’Neill AJ, Bouchier-Hayes DM, Sweeney P, et al. Nitric oxide in unilateral ureteral obstruction: Effect on regional renal blood flow. Kidney Int. 2001; 59:1059-65.
- 11. Chevalier RL, Thornhill BA, Gomez RA. EDRF modulates renal hemodynamics during unilateral ureteral obstruction in the rat. Kidney Int. 1992; 42:400-6.10.1038/ki.1992.301
- 12. Eiam-Ong S, Udom J, Sueblinvong T, Eiam-Ong S. Apoptosis of circulating lymphocyte in rats with unilateral ureteral obstruction: Role of angiotensin II. Nephrology. 2005; 10:464-9.10.1111/j.1440-1797.2005.00440.x
- 13. Manucha W, Oliveros L, Carrizo L, Seltzer A, Valles P. Losartan modulation on NOS isoforms and COX-2 expression in early renal fibrogenesis in unilateral obstruction. Kidney Int. 2004; 65:2091-107.
- 14. Eiam-Ong S, Jerawatana R, Kittikowit W, Mannontarat R, Tirawatnapong T, Eiam-Ong S. Effects of vanadate and potassium depletion on renal H,K-ATPase protein expression. Asian Biomed. 2009; 3:517-23.
- 15. Seujang Y, Kittikowit W, Eiam-Ong S, Eiam-Ong S. Lipid peroxidation and renal injury in renal ischemic reperfusion: Effect of angiotensin inhibition. J Med Assoc Thai. 2006; 89:1686-93.
- 16. Kurokawa K. Renal metabolism in obstructive nephropathy. Semin Nephrol. 1982;2:31-9.
- 17. Arnet UA, Mcmillan A, Dinerman JL, Ballermann B, Lowenstein CJ. Regulation of endothelial nitric oxide synthase doing hypoxia. J Biol Chem. 1996; 271:15069-73.
- 18. Le Cras TD, Xue C, Rengasamy A, Johns RA. Chronic hypoxia upregulates endothelial and inducible NOS synthase gene and protein expression in rat lung. Am J Physiol. 1996; 270:L164-70.
- 19. Arima S, Ito S. New insights into actions of the reninangiotensin system in the kidney: concentrating on the Ang II receptors and the newly described Ang-(1-7) and its receptor. Semin Nephrol. 2001; 21:535-43.10.1053/snep.2001.26792
- 20. Siragy MH, Carey MR. The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J Clin Invest. 1997; 100:264-9.
- 21. Morrissey J, Klahr S. Effect of AT2 receptor blocker on the pathogenesis of renal fibrosis. Am J Physiol. 1999; 276:F39-45.
- 22. Ignjatovic T, Tan F, Brovkovych V. Activation of bradykinin B1 receptor by ACE inhibitors. Int Immunopharmacol. 2002; 2:1787-93.10.1016/S1567-5769(02)00146-7
- 23. Ferri C, Desideri G, Baldoncini R, Bellini C, Valenti M, Santucci A, et al. Angiotensin II increases the release of endothelin-1 from human cultured endothelial cells but does not regulate its circulation levels. Clin Sci. 1999; 96:261-70.
- 24. Feldman DL, Mogelesky TC, Chou M, Jeng AY. Enhanced expression of renal endothelin converting enzyme-1 and endothelin-A-receptor mRNA in rats with interstitial fibrosis following ureter ligation. J Cardiovasc Pharmacol. 2000; 36:S255-9.
- 25. Moridaira K, Morrissey J, Fitzgerald M, Guo G, McCracken R, Tolley T, et al. ACE inhibition increases expression of the ETB receptor in kidneys of mice with unilateral obstruction. Am J Physiol. 2003; 284: F209-17.
- 26. Karaki H, Sudjarwo SA, Hori M, Takai M, Urade Y, Okada T. Induction of endothelium-dependent relaxation in the rat aorta by IRL 1620, a novel and selective agonist at the endothelin ETB receptor. Br J Pharmacol. 1993; 109:486-90.
- 27. Knerr I, Dittrich K, Miller J, Kummer W, Rösch W, Weidner W, et al. Alteration of neuronal and endothelial nitric oxide synthase and neuropeptide Y in congenital ureteropelvic junction obstruction. Urol Res. 2001; 29:134-40.10.1007/s002400000165
- 28. Nakayama I, Kawahara Y, Tsuda T, Okuda M, Yokoyama M. Angiotensin II inhibits cytokine-stimulated iNOS expression in vascular smooth muscle cell. J Biol Chem. 1994; 269:11628-33.
- 29. Miyajima A, Chen J, Kirmman I, Poppas DP, Darracott Vaughan E JR, Felsen D. Interaction of nitric oxide and transforming growth factor -b1 induced by angiotensin II and mechanical stretch in rat renal tubular epithelial cells. J Urology. 2000; 164:1729-34.
- 30. Schanstra JP, Neau E, Drogoz P, Arevalo Gomez MA, Lopez Novoa JM, Calise D, et al. In vivo bradykinin B2 receptor activation reduces renal fibrosis. J Clin Invest. 2002; 110:371-9.